Look for:

MITHRA PHARMACEUTICALS S.A.


ISIN:
BE0974283153
WKN:
-
2024/04/18 17:35:25
Price
0.233 EUR
Difference 5.67% (0.01)

General attributes

ISINBE0974283153
SymbolMITRA
ExchangeEuronext Brussels
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.2235 EUR
High0.2335 EUR
Low0.221 EUR
Close (prev. day)0.2205 EUR
VWAP0.228231 EUR
Volume (pcs)36,373
Trading volume8,301.00
Number of trades43
Last size1

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/18 17:35:25
Price
0.233 EUR
Difference 5.67% (0.01)

General attributes

ISINBE0974283153
SymbolMITRA
ExchangeEuronext Brussels
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16 EUR
BenchmarkBEL 20 INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.2235 EUR
High0.2335 EUR
Low0.221 EUR
Close (prev. day)0.2205 EUR
VWAP0.228231 EUR
Volume (pcs)36,373
Trading volume8,301.00
Number of trades43
Last size1

Performance and Risk

6m1y3y
Perf (%)-79.05%-92.28%-99.11%
Perf (abs.)-0.88-2.79-25.87
Beta0.530.580.77
Volatility113.94105.1874.98
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.228 EUR (71,547)
Ø price 30 days | Ø volume 30 days (pcs.)0.238 EUR (404,585)
Ø price 100 days | Ø volume 100 days (pcs.)0.756 EUR (295,813)
Ø price 250 days | Ø volume 250 days (pcs.)1.487 EUR (261,778)
YTD High | date1.360 EUR (2024/01/02)
YTD Low | date0.201 EUR (2024/03/11)
52 Weeks High | date3.870 EUR (2023/08/08)
52 Weeks Low | date0.201 EUR (2024/03/11)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/04/1822:020.2325 EUR0.001
Stuttgart2024/04/1808:110.2195 EUR0.003
Munich2024/04/1808:020.2325 EUR0.002
London Stock Exchange European Trade Reporting2024/04/1817:300.2275 EUR0.002
Frankfurt2024/04/1808:020.18 EUR0.002
FINRA other OTC Issues2023/12/0202:106.75 USD0.001
Euronext Brussels2024/04/1817:350.233 EUR0.0143
Duesseldorf2024/04/1815:020.2335 EUR0.002
Berlin2024/04/1821:500.232 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=138804&ID_TYPE_IMAGE_LOGO=2

Contact Details

MITHRA PHARMACEUTICALS SA
- -
rue Saint-Georges 5 - 4000 Liege
Telefon: +32-4-349-28-22
Fax: +32-4-349-28-21
E-mail: info@mithra.com

Company Profile

-

Members of Management Board

David Horn SolomonChairman of Managing Board
Benjamin BrandsMember of Executive Committee
Christophe MaréchalMember of Executive Committee
Graham DixonMember of Executive Committee
Jean-Manuel FontaineMember of Executive Committee
Jean-Michel FoidartMember of Executive Committee

Board of directors

Christian HomsyChairman of Supervisory Board
Jean-Michel FoidartMember of Supervisory Board
Inge BeernaertMember of Supervisory Board
Jacques GalloyMember of Supervisory Board
Valérie GordenneMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.